AVTR News and Press, Avantor Inc. From 07/24/24

Avantor, Inc. (NYSE: AVTR) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 6.45% on the day to $22.54. Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advance...

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 PR Newswire NEW YORK , July 23, 2024 /PRNewswir...

2024-07-19 10:32:47 ET Summary Danaher Corporation stock saw a high single-digit percentage increase from April to mid-June, but has since given up most of the gains. Concerns about inventory destocking in the bioprocessing market have impacted investor sentiment, but expectations...

2024-07-16 15:02:29 ET National Institutes of Health outlays increased by about 5% in June 2024 Y/Y to $4.218B, according to Baird Equity Research.... Read the full article on Seeking Alpha For further details see: NIH outlays rise by 5% in June, says Baird

2024-07-12 14:30:06 ET More on Exact Sciences: Exact Sciences: Still No Reason To Own Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics Exact Sciences gains a...

2024-07-10 16:27:15 ET More on Agilent Technologies, Avantor, etc. Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out Agilent Hit By Cyclical Headwinds, But The Growth Story Remains Intact Long Term Agilent Technologies, Inc. ...

2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for AVTR on July 2, 2024 07:56AM ET. The previous analyst recommendation was Outperform. AVTR was trading at $20.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-07-01 09:35:27 ET More on Avantor Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript Avantor, Inc. 2024 Q1 - Results - Earnings Call Presentation Avantor rebounds after reaffirming outlook Avantor Q1 2024 Earnings Preview Seeking Alpha’s...

Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease PR Newswire Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Av...

Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024 PR Newswire RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...